# What the numbers in des(1–3)IGF-1 mean

- Article ID: research-194
- Product: IGF-1 DES 1,3 (igf-1-des-1-3-440)
- Canonical page: https://heritagebiolabs.com/research-library/articles/194-what-the-numbers-in-des-13-igf-1-mean
- Product collection: https://heritagebiolabs.com/research-library/products/igf-1-des-1-3
- Product page: https://heritagebiolabs.com/product/igf-1-des-1-3-440
- Reading focus: Study findings (Reading focus is a navigational tag, not an evidence grade.)
- Source years: 1986, 1989, 2026

> Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend.

Peptides are short chains of amino acids joined by peptide bonds. Longer chains can fold into hormones and carry growth signals. IGF-1 DES 1,3 is a catalog name commonly used for des(1–3)IGF-1, a 67-residue form of insulin-like growth factor 1 with the first three amino acids removed. What does that notation tell us about its identity and the older tissue research? [1, 2, 3]

Full-length human IGF-1 has 70 residues. The numbering in des(1–3) describes three consecutive positions at the beginning of the mature chain. In an older experiment, researchers separated several IGF-1-related substances from pig uterine extracts and determined their sequences. They identified material consistent with removal of the first three amino acids and other materials shortened by different amounts. Counting exactly how many residues were missing distinguished the molecules within the same group of fractions. [1, 2]

Another older study isolated a form of IGF-1 with a shortened starting end from adult human brain extracts. Both groups used extraction and laboratory separation procedures. Identifying a shortened peptide in a tissue extract establishes what the researchers measured in the prepared material. It does not by itself establish its concentration in living tissue, when the truncation occurred, or what it does during a person's lifetime. [2, 3]

No recent primary study was identified here that supersedes those specific sequence-identification experiments. The older findings explain the name and show why a truncated chain must be identified by the sequence rather than by the broader IGF-1 family name. They do not verify an individual commercial sample. Full-length recombinant human IGF-1 is also a distinct medicine with its own regulatory label. [1, 2, 3]

## Sources

1. Eton Pharmaceuticals, Inc. INCRELEX (mecasermin) injection, for subcutaneous use. DailyMed (label effective 2026-05-18). <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5b2b0e1-c523-468d-9a0b-4ae4e4a8dbce>
2. Ogasawara M et al. Identification and purification of truncated insulin-like growth factor I from porcine uterus. Evidence for high biological potency. Biochemistry (publication 1989-03-21). <https://pubmed.ncbi.nlm.nih.gov/2730884/>
3. Carlsson-Skwirut C et al. Isolation and characterization of variant IGF-1 as well as IGF-2 from adult human brain. FEBS Letters (publication 1986-05-26). <https://pubmed.ncbi.nlm.nih.gov/3709807/>

## Provenance

Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed. Source volume: Peptide Research Articles 039 - IGF-1 Human and IGF-1 DES 1 3.docx; article 194; content SHA-256 ad78b8c31edeaa2651e06bbd5a59ba3e3de6f2f216da2f8df1602219ae4d93b3.
